Green intelligent manufacturing empowers the billion dollar race track, modern peptide factories lead the new transformation of the biotechnology industry

In the current booming bioeconomy, peptide products have become the core engine of pharmaceutical innovation, precision nutrition, beauty technology and other fields with their core advantages of precise targeting and high safety. As a key hub for industrial transformation, peptide factories are reshaping the development pattern of the industry with green technology, full chain services, and large-scale production capacity, injecting sustained momentum into the global health industry.

The core breakthrough of modern peptide factories lies in the innovation of green processes. Abandoning the high pollution drawbacks of traditional synthesis, adopting yeast cell "micro factory" technology and green continuous liquid-phase synthesis process, the solvent consumption is reduced by 400 times compared to traditional methods, achieving efficient and environmentally friendly production of peptide compounds. The fusion of solid-phase and liquid-phase synthesis technology, combined with an AI driven sequence design system, can achieve rapid screening of billions of peptide compounds, as well as precise mass production of complex products such as macrocyclic peptides and modified peptides. The purity is stable at over 99%, meeting the high-end application needs of antibacterial and anti-tumor applications.

The layout of the entire industry chain has become the core competitiveness of peptide factories. We have established a traceable quality assurance system from the centralized collection of natural raw materials such as deep-sea cod skin and high-quality plant protein from the North Atlantic, to the intelligent production of 100000 level clean workshops, and to the full process quality control of HPLC purification and mass spectrometry detection. Based on the academician workstation and university research platform, we will provide one-stop services from formula research and development, dosage form optimization to compliance declaration, supporting the production of full dosage forms such as powders, oral liquids, capsules, etc. Our annual production capacity can reach 3000 tons, catering to diverse needs from small-scale trial production of start-up brands to large-scale OEM of mature enterprises.

Driven by both policy dividends and market demand, the application boundaries of peptide factories continue to expand. Our products have covered areas such as chronic disease management specialty food, anti-aging beauty ingredients, and new antibiotics. Our cooperative brands are located in more than 50 countries and regions around the world. Transforming from a "global supplier" to an "innovation hub", these peptide factories are using technological innovation to solve industry pain points, building a solid quality foundation with strict standards, and becoming the core force driving the implementation of the Healthy China strategy in the trillion dollar bio industry track.